Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
ADMINISTRATION OF H2 BLOCKERS IN NSAID INDUCED GASTROPATHY IN RATS: effect on histopathological changes in gastric,
Sachin Manocha1, Dushyant Lal2, Subramanian Venkataraman3
1Department of Pharmacology, Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi, India, Vardhaman Mahaveer Open University, Department of Pharmacology, Vardhaman Mahavir Medical College, Safdarjung Hospital, New Delhi , India.
Background:
Nonsteroidal anti-inflammatory drugs induces gastric mucosal lesions because of its acidic properties. Ranitidine, an H2 receptor antagonist, has proved beneficial in patients with gastric ulcers.
Objective:
The present study was performed to assess the effect of administering ranitidine in Nonsteroidal anti-inflammatory drugs (diclofenac, nimesulide) induced gastropathy, and their effect on the histopathology of stomach, kidney and liver.
Methods:
Diclofenac, nimesulide, and ranitidine were administered in doses of 2, 4, and 6 mg/kg, p.o. once daily for 14 days, and their effect on gastric volume, acidity, mean ulcer number, and gastric pH. In addition, histopathological examination was also performed on sections of stomach, kidney and liver.
Results:
Following the administration of diclofenac or nimesulide, all the gastric parameters were significantly altered as well as the histopathology of stomach, liver and kidney. In the control group, the renal sections showed normal glomeruli with no thickening of glomerular basement membrane, while in diclofenac alone, nimesulide alone, and ranitidine with nimesulide groups, the thickening of glomerular basement membrane was observed. These alterations were observed to be reversed in the ranitidine with diclofenac group. In the sections from the liver, the control group showed anastomosing plates and cords of cuboidal hepatocytes with round well stained nuclei and abundant cytoplasm. In the ranitidine with diclofenac, and ranitidine with nimesulide groups, mild dilatation of sinusoids is seen coupled with prominence of central vein. In the diclofenac alone and nimesulide alone groups, the proximal and distal convoluted tubules show mild focal tubular necrosis. In the gastric sections, the control group showed several folds forming villi, and the epithelial lining surface of the mucosa. In the ranitidine with diclofenac, and ranitidine with nimesulide groups, the duodenum showed scattered inflammatory cells composed predominantly of lymphocytes. In diclofenac alone and nimesulide alone group, the sections from the gastric areas showed partial necrosis and mild chronic inflammation respectively.
Conclusion:
The study, therefore, has provided therapeutic rationale towards simultaneous administration of H2 receptor blocker ranitidine with diclofenac to be more beneficial as compared to ranitidine with nimesulide, to minimise the gastric intolerance of diclofenac in long term treatment of inflammatory conditions.
Insights
This study shows that combining ranitidine with diclofenac helps minimize gastric damage more effectively than combining it with nimesulide. This offers a therapeutic strategy for long-term anti-inflammatory drug use.
Area of Science:
- Gastroenterology and Pharmacology
- Toxicology and Pathology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause gastric mucosal lesions due to their acidic nature.
- Ranitidine, an H2 receptor antagonist, is known to be beneficial for gastric ulcers.
Purpose of the Study:
- To evaluate the protective effects of ranitidine against NSAID-induced gastropathy.
- To assess the impact of ranitidine and NSAIDs (diclofenac, nimesulide) on the histopathology of the stomach, kidney, and liver.
Main Methods:
- Administration of diclofenac, nimesulide, and ranitidine at varying doses (2, 4, 6 mg/kg) daily for 14 days.
- Monitoring of gastric parameters including volume, acidity, ulcer count, and pH.
- Histopathological examination of stomach, kidney, and liver tissues.
Main Results:
- NSAIDs significantly altered gastric parameters and caused histopathological damage in the stomach, liver, and kidney.
- Ranitidine with diclofenac reversed kidney damage (glomerular basement membrane thickening), unlike ranitidine with nimesulide.
- NSAID-induced tubular necrosis in the liver and gastric inflammation were observed, with varying effects of ranitidine combinations.
Conclusions:
- Simultaneous administration of ranitidine with diclofenac is therapeutically beneficial.
- This combination is more effective than ranitidine with nimesulide in minimizing gastric intolerance to diclofenac.
- Provides a rationale for using ranitidine with diclofenac in long-term anti-inflammatory treatment.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

